PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
500
about 3 years
18+
1 site in NC
About this study
This trial is testing whether a precision oncology navigator and expert review of genomic sequencing can help more patients get treatments that are tailored to their specific cancer. The goal is to see if this approach leads to more people enrolling in clinical trials and improves survival rates.
Based on ClinicalTrials.gov records.
What participants do
- 1.Blood or tissue samples collection
- 2.Expert Review
- 3.The Precision Oncology Navigation
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Secondary: Overall Survival in subjects who are eligible for Level 1/2 genome-informed therapy (GIT), Overall survival (OS), The combined rate of orders for Level 1/2 GIT and consent to biomarker-directed clinical trials, The rates of consent to UNC Health biomarker-selective clinical trials
Oncology